Adrenodoxin supports reactions catalyzed by microsomal steroidogenic cytochrome P450s

Biochemical and Biophysical Research Communications

Volumn 353, Issue 3, 2007, Pages 598-604

  Pechurskaya, Tatiana A ^a   Harnastai, Ivan N ^a   Grabovec, Irina P ^a   Gilep, Andrei A ^a   Usanov, Sergey A ^a  

^a INSTITUTE FOR MATHEMATICS   (Belarus)

Author keywords

Adrenodoxin; CYP17; CYP19; CYP21; Cytochrome P450; Electron transfer; Microsomal proteins; NADPH cytochrome P450 reductase; Steroid biosynthesis; Truncated proteins

Indexed keywords

ADRENODOXIN; CYTOCHROME P450; CYTOCHROME P450 17; CYTOCHROME P450 REDUCTASE; STEROID 21 MONOOXYGENASE;

ARTICLE; ELECTRON TRANSPORT; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME PURIFICATION; ENZYME SUBSTRATE COMPLEX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IONIC STRENGTH; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ADRENODOXIN; AMINO ACID SEQUENCE; AROMATASE; FERREDOXIN-NADP REDUCTASE; HUMANS; MOLECULAR SEQUENCE DATA; NADPH-FERRIHEMOPROTEIN REDUCTASE; SEQUENCE ALIGNMENT; STEROID 17-ALPHA-HYDROXYLASE; STEROID 21-HYDROXYLASE;

EID: 33846112677     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.12.047     Document Type: Article

References (30)

1. Sakaguchi M., Mihara K., and Sato R. Signal recognition particle is required for co-translational insertion of cytochrome P-450 into microsomal membranes. Proc. Natl. Acad. Sci. USA 81 (1984) 3361-3364
2. Neve E.P., and Ingelman-Sundberg M. A soluble NH(2)-terminally truncated catalytically active form of rat cytochrome P450 2E1 targeted to liver mitochondria. FEBS Lett. 460 (1999) 309-314
3. Sagara Y., Barnes H.J., and Waterman M.R. Expression in Escherichia coli of functional cytochrome P450c17 lacking its hydrophobic amino-terminal signal anchor. Arch. Biochem. Biophys. 304 (1993) 272-278
4. Li Y.C., and Chiang J.Y. The expression of a catalytically active cholesterol 7 alpha-hydroxylase cytochrome P450 in Escherichia coli. J. Biol. Chem. 266 (1991) 19186-19191
5. Pernecky S.J., Olken N.M., Bestervelt L.L., and Coon M.J. Subcellular localization, aggregation state, and catalytic activity of microsomal P450 cytochromes modified in the NH2-terminal region and expressed in Escherichia coli. Arch. Biochem. Biophys. 318 (1995) 446-456
6. von Wachenfeldt C., Richardson T.H., Cosme J., and Johnson E.F. Microsomal P450 2C3 is expressed as a soluble dimer in Escherichia coli following modification of its N-terminus. Arch. Biochem. Biophys. 339 (1997) 107-114
7. Gillam E.M., Baba T., Kim B.R., Ohmori S., and Guengerich F.P. Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. Arch. Biochem. Biophys. 305 (1993) 123-131
8. Dong M.S., Yamazaki H., Guo Z., and Guengerich F.P. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase. Arch. Biochem. Biophys. 327 (1996) 11-19
9. Anandatheerthavarada H.K., Addya S., Mullick J., and Avadhani N.G. Interaction of adrenodoxin with P4501A1 and its truncated form P450MT2 through different domains: differential modulation of enzyme activities. Biochemistry 37 (1998) 1150-1160
10. Hlavica P., Schulze J., and Lewis D.F. Functional interaction of cytochrome P450 with its redox partners: a critical assessment and update of the topology of predicted contact regions. J. Inorg. Biochem. 96 (2003) 279-297
11. Sakaki T., Kominami S., Hayashi K., Akiyoshi-Shibata M., and Yabusaki Y. Molecular engineering study on electron transfer from NADPH-P450 reductase to rat mitochondrial P450c27 in yeast microsomes. J. Biol. Chem. 271 (1996) 26209-26213
12. Sagara Y., Hara T., Ariyasu Y., Ando F., Tokunaga N., and Horiuchi T. Direct expression in Escherichia coli and characterization of bovine adrenodoxins with modified amino-terminal regions. FEBS Lett. 300 (1992) 208-212
13. Sagara Y., Wada A., Takata Y., Waterman M.R., Sekimizu K., and Horiuchi T. Direct expression of adrenodoxin reductase in Escherichia coli and the functional characterization. Biol. Pharm. Bull. 16 (1993) 627-630
14. Guzov V.M., Zel'ko I.N., Chudaev M.V., Guzova Iu A., Bon-Chu C., and Usanov S.A. Expression of functionally active human cytochrome P-450c21 (CYPXXIA2) in Escherichia coli and single-stage purification of it using metal-affinity chromatography. Biokhimiia 61 (1996) 1758-1771
15. Gilep A.A., Estabrook R.W., and Usanov S.A. Molecular cloning and heterologous expression in E. coli of cytochrome P45017alpha. Comparison of structural and functional properties of substrate-specific cytochromes P450 from different species. Biochemistry (Mosc) 68 (2003) 86-98
16. Harnastai I.N., Gilep A.A., and Usanov S.A. The development of an efficient system for heterologous expression of cytochrome P450s in Escherichia coli using hemA gene co-expression. Protein Expr. Purif. 46 (2006) 47-55
17. Omura T., and Sato R. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239 (1964) 2370-2378
18. Gilep A.A., Guryev O.L., Usanov S.A., and Estabrook R.W. An enzymatically active chimeric protein containing the hydrophilic form of NADPH-cytochrome P450 reductase fused to the membrane-binding domain of cytochrome b5. Biochem. Biophys. Res. Commun. 284 (2001) 937-941
19. Mo H., Pochapsky S.S., and Pochapsky T.C. A model for the solution structure of oxidized terpredoxin, a Fe2S2 ferredoxin from Pseudomonas. Biochemistry 38 (1999) 5666-5675
20. Porter T.D., Wilson T.E., and Kasper C.B. Expression of a functional 78,000 dalton mammalian flavoprotein, NADPH-cytochrome P-450 oxidoreductase, in Escherichia coli. Arch. Biochem. Biophys. 254 (1987) 353-367
21. Larson J.R., Coon M.J., and Porter T.D. Alcohol-inducible cytochrome P-450IIE1 lacking the hydrophobic NH2-terminal segment retains catalytic activity and is membrane-bound when expressed in Escherichia coli. J. Biol. Chem. 266 (1991) 7321-7324
22. Black S.D., and Coon M.J. Structural features of liver microsomal NADPH-cytochrome P-450 reductase. Hydrophobic domain, hydrophilic domain, and connecting region. J. Biol. Chem. 257 (1982) 5929-5938
23. Otto D.M., Henderson C.J., Carrie D., Davey M., Gundersen T.E., Blomhoff R., Adams R.H., Tickle C., and Wolf C.R. Identification of novel roles of the cytochrome p450 system in early embryogenesis: effects on vasculogenesis and retinoic acid homeostasis. Mol. Cell. Biol. 23 (2003) 6103-6116
24. Henderson C.J., Otto D.M., Carrie D., Magnuson M.A., McLaren A.W., Rosewell I., and Wolf C.R. Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase. J. Biol. Chem. 278 (2003) 13480-13486
25. Fluck C.E., and Miller W.L. P450 oxidoreductase deficiency: a new form of congenital adrenal hyperplasia. Curr. Opin. Pediatr. 18 (2006) 435-441
26. Fukami M., Hasegawa T., Horikawa R., Ohashi T., Nishimura G., Homma K., and Ogata T. Cytochrome P450 oxidoreductase deficiency in three patients initially regarded as having 21-hydroxylase deficiency and/or aromatase deficiency: diagnostic value of urine steroid hormone analysis. Pediatr. Res. 59 (2006) 276-280
27. Dus K. On the structure of putidaredoxin and cytochrome P-450 cam and their mode of interaction. Adv. Exp. Med. Biol. 58 (1975) 287-309
28. Lehnerer M., Schulze J., Bernhardt R., and Hlavica P. Some properties of mitochondrial adrenodoxin associated with its nonconventional electron donor function toward rabbit liver microsomal cytochrome P450 2B4. Biochem. Biophys. Res. Commun. 254 (1999) 83-87
29. Usanov S.A., Graham S.E., Lepesheva G.I., Azeva T.N., Strushkevich N.V., Gilep A.A., Estabrook R.W., and Peterson J.A. Probing the interaction of bovine cytochrome P450scc (CYP11A1) with adrenodoxin: evaluating site-directed mutations by molecular modeling. Biochemistry 41 (2002) 8310-8320
30. Wada A., and Waterman M.R. Identification by site-directed mutagenesis of two lysine residues in cholesterol side chain cleavage cytochrome P450 that are essential for adrenodoxin binding. J. Biol. Chem. 267 (1992) 22877-22882